Press releaseGlobe Newswire
Arbutus Biopharma
ABUS · NASDAQ
$4.33+$0.10 (+2.36%)TodayMarket closed ·
Prev close $4.23
Latest news
- Press releaseGlobe Newswire
Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
- News
10 Health Care Stocks With Whale Alerts In Today’s Session
- Press releaseGlobe Newswire
Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share
- NewsVandana Singh
Why Is Arbutus Biopharma Stock Gaining Friday?
- Press releaseGlobe Newswire
Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
- News
Arbutus Biopharma Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.014M Beat $700.000K Estimate
- Press releaseGlobe Newswire
Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update
- News
Arbutus Biopharma Q1 EPS $0.87 Beats $(0.04) Estimate, Sales $179.126M Beat $750.000K Estimate
- Press releaseGlobe Newswire
Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update
- NewsVandana Singh
Europe Clears First Flu/COVID Combo Shot From Moderna
- NewsAvi Kapoor
QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
- NewsAvi Kapoor
Why J B Hunt Transport Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B
- Press releaseGlobe Newswire
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
- NewsVandana Singh
Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars
- NewsAvi Kapoor
Staar Surgical Posts Downbeat Q4 Results, Joins Webtoon Entertainment, Gitlab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- Press releaseGlobe Newswire
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
- Press releaseGlobe Newswire
Roivant Announces Genevant Sciences' and Arbutus Biopharma's $2.25 Billion Global Settlement With Moderna
- Press releaseGlobe Newswire
Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update
- Press releaseGlobe Newswire
Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025
- Press releaseGlobe Newswire
Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update
- Press releaseGlobe Newswire
Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
- Press releaseGlobe Newswire
Arbutus Provides 2025 Corporate and Financial Update
- Press releaseBusiness Wire
Whitefort Capital Sends Letter to Arbutus Biopharma Board of Directors
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.